SUCAMPO PHARMA, LLC
合同会社 (合) · CHIYODA KU, Japan · LEI 549300QZDP780EI1IT13
LEI lapsed
Summary
SUCAMPO PHARMA, LLC is registered in Japan. Its legal form is 合同会社 (合). According to GLEIF, its ultimate parent is MALLINCKRODT PUBLIC LIMITED COMPANY (Ireland), and its direct parent is Sucampo Pharmaceuticals, Inc. (United States). That group has 7 subsidiaries with LEIs in 6 countries, 1 of them in Japan. The LEI was first issued on 13 Apr 2018 and the record was last updated on 31 Jul 2023. It has lapsed: renewal was due by 1 Mar 2022. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 1 Mar 2022 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 25 Dec 2020, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 31 Jul 2023.
Company details
| Legal form | 合同会社 (合) |
|---|---|
| Jurisdiction | Japan |
| Registered address | 1-7, UCHISAIWAICHO 1-CHOME, 100-6213 CHIYODA KU, Japan |
| Headquarters address | 675 MCDONNELL BOULEVARD, 63042 HAZELWOOD, United States |
| Category | company or other legal entity |
| Status | active |
| LEI | 549300QZDP780EI1IT13 |
| LEI status | lapsed |
| LEI first issued | 13 Apr 2018 |
| LEI record last updated | 31 Jul 2023 |
| Next LEI renewal | 1 Mar 2022 |
| Corroboration of the LEI record | supplied by the entity only |
Group membership
SUCAMPO PHARMA, LLC this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Sucampo Pharmaceuticals, Inc. | MALLINCKRODT PUBLIC LIMITED COMPANY |
| Accounting period | 1 Jan 2020 to 31 Dec 2020 | 26 Dec 2019 to 25 Dec 2020 |
| Evidence | supporting documents | consolidated accounts |
| Corroboration | supplied by the entity only | fully corroborated |
| Accounting standard | – | US GAAP |
| Relationship start | 12 Apr 2018 | 12 Apr 2018 |
| Recorded at GLEIF since | 13 Apr 2018 | 13 Apr 2018 |
| Last updated | 31 Jul 2023 | 31 Jul 2023 |
| Record status | not renewed | not renewed |
Other names
- Sucampo Pharma LLC · previous name